Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability

被引：0
|
作者：
Abou Chakra, Mohamad [1 ]
Moussa, Mohamad [2 ]
O'Donnell, Michael A. [1 ]
机构：
[1] Univ IA, Dept Urol, Iowa City, IA 52242 USA
[2] Lebanese Univ, Al Zahraa Hosp, Dept Urol, Beirut, Lebanon
来源：
JOURNAL OF CHEMOTHERAPY | 2024年 / 36卷 / 08期
关键词：
RESCUE THERAPY; DOCETAXEL;
D O I：
10.1080/1120009X.2024.2325765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：694 / 697
页数：4
相关论文
共 50 条
  • [41] Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guerin for the treatment of high-risk, treatment-naive, non-muscle invasive bladder cancer.
    McElree, Ian M.
    Steinberg, Ryan L.
    Mott, Sarah L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [42] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Pak, Jamie S.
    Laplaca, Caroline
    Reyes, Helena Vila
    DeCastro, G. Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    McKiernan, James M.
    Lenis, Andrew T.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
  • [43] INTRAVESICAL THERAPY FOLLOWING TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Wang, Wei
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 36 - 36
  • [44] The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
    Douglass, Laura
    Schoenberg, Mark
    BLADDER CANCER, 2016, 2 (03) : 285 - 292
  • [45] BACILLUS CALMETTE-GUERIN VERSUS SEQUENTIAL GEMCITABINE AND DOCETAXEL FOR TA HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER
    Eraky, Ahmed
    Hug, Brenda
    Kolanukuduru, Kaushik P.
    Ben-David, Reuben
    Almoflihi, Mohammed
    Waigankar, Nikhil
    Attalla, Kyrollis
    Wiklund, Peter
    Mehrazin, Reza
    Sfakianos, John P.
    JOURNAL OF UROLOGY, 2025, 213 (5S):
  • [46] Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer
    Weintraub, Michael D.
    Li, Qingdi Quentin
    Agarwal, Piyush K.
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 656 - 660
  • [47] BCG INDUCTION WITH GEMCITABINE/DOCETAXEL MAINTENANCE VS. GEMCITABINE/DOCETAXEL INDUCTION AND MAINTENANCE AS ADJUVANT THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
    Ben, David Reuben
    Neeraja, Tillu
    Parissa, Alerasool
    Reza, Mehrazin
    Peter, Wiklund
    John, Sfakianos P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S56 - S56
  • [48] Intravesical Therapies in Non-muscle Invasive Bladder Tumors
    Geyik, Serdar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2019, 18 (01): : 24 - 29
  • [49] Intravesical therapy of non-muscle invasive bladder tumors
    vom Dorp, F.
    Tschirdewahn, S.
    Luemmen, G.
    UROLOGE, 2012, 51 (02): : 257 - 262
  • [50] INTRAVESICAL GEMCITABINE AND DOCETAXOL IN HEAVILY PRE-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Caruso, Adele
    Ravishankar, Roshan
    VanArsdalen, Keith
    Malkowicz, Stanley
    JOURNAL OF UROLOGY, 2020, 203 : E1124 - E1124
12345